Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00352079
What this trial is testing

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Who this might be right for
Bladder Cancer
NCIC Clinical Trials Group 41
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05483868
What this trial is testing

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder CancerNMIBCNon-Muscle Invasive Bladder Carcinoma+3 more
Aura Biosciences 55
Testing effectiveness (Phase 2)Looking for participantsNCT06704191
What this trial is testing

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Who this might be right for
Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+1 more
Mayo Clinic 40
Not applicableEnded earlyNCT02145390
What this trial is testing

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Bladder CancerBladder CarcinomaTransition Cell Cancer+1 more
University of Miami 1
Early research (Phase 1)Study completedNCT02144051
What this trial is testing

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

Who this might be right for
Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
AstraZeneca 32
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT05951179
What this trial is testing

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 131
Testing effectiveness (Phase 2)Looking for participantsNCT06394570
What this trial is testing

Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Texas Southwestern Medical Center 19
Testing effectiveness (Phase 2)Study completedNCT03980041
What this trial is testing

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

Who this might be right for
Bladder CancerUrothelial CarcinomaSolid Tumor+1 more
Infinity Pharmaceuticals, Inc. 49
Testing effectiveness (Phase 2)WithdrawnNCT05120622
What this trial is testing

Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh-Risk CancerTremelimumab+2 more
University of British Columbia
Early research (Phase 1)Study completedNCT02300610
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
H. Lee Moffitt Cancer Center and Research Institute 10
Large-scale testing (Phase 3)Study completedNCT00006124
What this trial is testing

Celecoxib in Treating Patients With Bladder Cancer

Who this might be right for
Recurrent Bladder Cancer
National Cancer Institute (NCI) 152
Early research (Phase 1)Looking for participantsNCT06351904
What this trial is testing

RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics. 72
Testing effectiveness (Phase 2)Looking for participantsNCT07087860
What this trial is testing

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more
Mayo Clinic 70
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Not applicableStudy completedNCT00772018
What this trial is testing

Quality of Life and Symptom Management in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
David Latini 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01520038
What this trial is testing

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

Who this might be right for
Urothelial Carcinoma of the Bladder
Abramson Cancer Center at Penn Medicine 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03601455
What this trial is testing

Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaStage IV Bladder Cancer AJCC v8Stage IVA Bladder Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 13
Next Page